Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs.

Setia, Aseem; Sahu, Ram Kumar; Ray, Supratim; Widyowati, Retno; Ekasari, Wiwied; Saraf, Swarnlata

Setia, Aseem; Sahu, Ram Kumar; Ray, Supratim; Widyowati, Retno; Ekasari, Wiwied; Saraf, Swarnlata.

Afiliação

Setia A; Department of Pharmacy, Shri Rawatpura Sarkar University, Raipur, (C.G) - 492015, India.
Sahu RK; Department of Pharmaceutical Sciences, Assam University (A Central University), Silchar-788011, Assam, India.
Ray S; Department of Pharmaceutical Sciences, Assam University (A Central University), Silchar-788011, Assam, India.
Widyowati R; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, 60115, Indonesia.
Ekasari W; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Surabaya, 60115, Indonesia.
Saraf S; Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492010, Chhattisgarh, India.

Curr Drug Metab ; 23(9): 757-780, 2022.

Article em En | MEDLINE | ID: mdl-35761494

Assuntos

Antineoplásicos; Nanopartículas; Neoplasias; Humanos; Lipídeos/química; Sistemas de Liberação de Medicamentos/métodos; Antineoplásicos/uso terapêutico; Nanopartículas/química; Polímeros/química; Neoplasias/tratamento farmacológico

Palavras-chave

Anticancer hybrid vesicular; biocompatibility; cellular mechanism; nanomedicines; preparative method; specific targeting

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article